Forskning2021-07-09T10:56:13+00:00

Forskning

Samarbejde om forskning

Genetelligence har en stor interesse i samarbejde inden for forskning for yderligere at udvikle og optimere medicinsk behandling i fremtiden. Derfor samarbejder vi med forskellige internationale forskningsgrupper, universiteter, sundheds professionelle osv. Nedenfor kan du finde nogle danske eksempler på forskningssamarbejde.

Personalized Medicine for patients with depression and/or anxiety

The literature on pharmacogenomics as a tool to support antidepressant precision is burgeoning. In this prospective, single-blind randomized controlled design, the impact of pharmacogenomics guided versus standard antidepressant was evaluated. Participants were 213 outpatients diagnosed with major depressive disorder and/ or generalized anxiety disorder, randomized to receive pharmacogenomics guided (n [...]

The Parker Institute study

Preparation of a clinical study The Parker Institute, ZiteLab ApS and Genetelligence in collaboration investigate the efficacy and safety of pharmacogenetic-guided methotrexate treatment versus standard of care. A pilot study has been performed 2021 and a new clinical trial is in progress. Read more about concept mapping by e.g., [...]

Clinical study, personalized medication

Personal medicine in long term care. Prescribing safe and effective medications for older patients with multiple chronic diseases is a big challenge. Nursing home residents are treated with multiple medications and are at higher risk of adverse events due to polypharmacy and age-related factors. A study by Dorfman et [...]

The ICANPIC study

Personal medicine at community pharmacies in Canada The objective of the study was to evaluate the feasibility of implementing personalized medication services into community pharmacy practice and to assess the number of drug therapy problems identified as a result of pharmacogenomic screening. The study was carried out in two [...]

The ICANPIC study – part II

Personal medicine in Canada - part II In this part II implementation of pharmacogenomics in the clinical setting is investigated. While several clinical trials have demonstrated the clinical validity and utility of treatment guided by PGx, implementation of PGx tools in health care appears to lag behind. The primary [...]

The APOXY study

Biomarker for clinical studies The APOXY study was performed at Aalborg University hospital. The objective was to investigate oral controlled-release formulation and their influence on the relationship between pharmacokinetics and pharmacodynamics and the importance of pharmacogenomics The study included 15 healthy volunteers, who were treated with oxycodone. A pharmacogenetic [...]

Få din egen Personlig Medicinsk Profil nu
Go to Top